A Phase 1, Open-Label, Drug-Drug Interaction Study to Evaluate the Potential Effects of Ranitidine on the Pharmacokinetics of Lesinurad in Healthy Adult Male Subjects

Trial Profile

A Phase 1, Open-Label, Drug-Drug Interaction Study to Evaluate the Potential Effects of Ranitidine on the Pharmacokinetics of Lesinurad in Healthy Adult Male Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 08 Jan 2014

At a glance

  • Drugs Lesinurad (Primary) ; Ranitidine
  • Indications Duodenal ulcer; Gastric ulcer; Gout; Peptic ulcer
  • Focus Pharmacokinetics
  • Sponsors Ardea Biosciences
  • Most Recent Events

    • 08 Jan 2014 Status changed from active, no longer recruiting to completed.
    • 03 Sep 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 03 Aug 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top